Added: (Fri Dec 01 2023)

Pressbox (Press Release) - The Multiplex Assays Market is set to achieve a significant milestone, reaching $6.24 billion by 2030, with a Compound Annual Growth Rate (CAGR) of 9% during the forecast period, according to Meticulous Research®. Multiplex assays, facilitating the simultaneous detection of multiple analytes, have emerged as a crucial tool for clinicians, providing insights into the assessment and identification of disease progression.
Several factors contribute to the market's growth, including the distinct advantages of multiplex assays over singleplex assays, their application in companion diagnostics, the escalating prevalence of chronic and infectious diseases, and the increasing awareness of the importance of early disease diagnosis. However, the market faces challenges due to the high costs associated with multiplex assay equipment.
The need for high-throughput and automated laboratory systems, coupled with a growing focus on personalized medicine, presents lucrative opportunities for market players. Despite these prospects, challenges such as a shortage of skilled professionals and the risk of cross-reactivity pose obstacles to market growth.
Top 10 Companies in the Multiplex Assays Market: https://meticulousblog.org/top-10-companies-in-multiplex-assays-market/
1. Seegene, Inc. (South Korea):
• Founded in 1997
• Develops molecular diagnostic reagents
• Geographic presence in the U.S., Canada, South Korea, Brazil, Mexico, Italy, the Middle East, and Germany
2. F. Hoffmann-La Roche AG (Switzerland):
• Founded in 1896
• Healthcare company with divisions in Pharmaceuticals and Diagnostics
• Global presence across the U.S., Germany, Switzerland, Japan, China, India, New Zealand, Australia, Latin America, and Africa
3. Thermo Fisher Scientific, Inc. (U.S.):
• Founded in 1956
• Operates in pharmaceutical, biotechnology, clinical, healthcare, government, and academic sectors
• Direct presence in the U.S., Mexico, Brazil, Germany, Belgium, Austria, the U.K., Italy, the Netherlands, South Africa, the UAE, India, China, Japan, Australia, and the Republic of Korea
4. Illumina, Inc. (U.S.):
• Incorporated in 1998
• Provides sequencing- and array-based solutions for genomic and genetic analysis
• Global distribution in North America, Europe, Latin America, Asia-Pacific, and the Middle East & Africa
5. Qiagen N.V. (Netherlands):
• Founded in 1984
• Leading provider of sample and assay technologies for molecular diagnostics, applied testing, and research
• Global subsidiaries include Qiagen AB (Sweden), Qiagen AG (Sweden), Qiagen GmbH (Germany), QIAGEN LLC (U.S.), and more
6. Becton, Dickinson and Company (U.S.):
• Founded in 1897
• Medical technology firm offering medical devices, supplies, laboratory equipment, and diagnostic products
• Manufacturing facilities in multiple countries, subsidiaries include Becton Dickinson Canada Inc., Becton Dickinson GmbH (Germany), BD Rapid Diagnostic (Suzhou) Co., Ltd. (China), and more
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5598

7. Bio-Rad Laboratories, Inc. (U.S.):
• Founded in 1952
• Distributor and manufacturer of clinical diagnostics products and life science research
• Direct distribution in over 35 countries outside the U.S.
8. DiaSorin S.p.A (Italy):
• Founded in 1968
• Medical device company manufacturing immunodiagnostics and molecular diagnostics instruments, reagents, assays, and software
• Direct presence in 24 countries, indirect presence in 93 countries through distributors
9. PerkinElmer, Inc. (U.S.):
• Founded in 1937
• Multinational company offering products, solutions, and services for life sciences, diagnostics, and applied markets
• Manufacturing and R&D facilities in the U.S., China, Japan, and Germany
10. Agilent Technologies, Inc. (U.S.):
• Founded in 1999
• Provides application-focused solutions to life sciences, diagnostics, and applied chemical markets
• Global presence across North America, Europe, Asia–Pacific, Latin America, and the Middle East & Africa

Popular Mentions: Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), Merck KGaA (Germany), Quanterix Corporation (U.S.), and others.
Quick Buy : https://www.meticulousresearch.com/Checkout/82101470
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research sPvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

Submitted by:
Disclaimer: Pressbox disclaims any inaccuracies in the content contained in these releases. If you would like a release removed please send an email to remove@pressbox.com together with the url of the release.